Cellular mechanisms of the 5-HT7 receptor-mediated signaling

Frontiers in Behavioral Neuroscience

Volumn 8, Issue OCT, 2014, Pages

  Guseva, Daria ^a   Wirth, Alexander ^a   Ponimaskin, Evgeni ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

G protein coupled receptors; Heterotrimeric G protein; Oligomerization; Palmitoylation; Serotonergic signaling; Serotonin 5 HT7receptor

Indexed keywords

G PROTEIN COUPLED RECEPTOR; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; SEROTONIN 7 RECEPTOR; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA12; UNCLASSIFIED DRUG;

CALCIUM METABOLISM; DIMERIZATION; GENETIC VARIABILITY; HETERODIMERIZATION; HOMODIMERIZATION; HUMAN; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PALMITOYLATION; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FAMILY; RECEPTOR OCCUPANCY; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 84907527989     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2014.00306     Document Type: Review

References (94)

1. Adriani, W., Travaglini, D., Lacivita, E., Saso, L., Leopoldo, M., and Laviola, G. Modulatory effects of two novel agonists for serotonin receptor 7 on emotion, motivation and circadian rhythm profiles in mice. Neuropharmacology 62, 833-842. doi: 10.1016/j.neuropharm.2011.09.012
2. Amano, M., Ito, M., Kimura, K., Fukata, Y., Chihara, K., Nakano, T., et al. (1996). Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J. Biol. Chem. 271, 20246-20249. doi: 10.1074/jbc.271.34.20246
3. Bakalyar, H. A., and Reed, R. R. (1990). Identification of a specialized adenylyl cyclase that may mediate odorant detection. Science 250, 1403-1406. doi: 10. 1126/science.2255909
4. Baker, L. P., Nielsen, M. D., Impey, S., Metcalf, M. A., Poser, S. W., Chan, G., et al. (1998). Stimulation of type 1 and type 8 Ca2+/calmodulin-sensitive adenylyl cyclases by the Gs-coupled 5-hydroxytryptamine subtype 5-HT7A receptor. J. Biol. Chem. 273, 17469-17476. doi: 10.1074/jbc.273.28.17469
5. Ballaz, S. J., Akil, H., and Watson, S. J. (2007). The 5-HT7 receptor: role in novel object discrimination and relation to novelty-seeking behavior. Neuroscience 149, 192-202. doi: 10.1016/j.neuroscience.2007.07.043
6. Bard, J. A., Zgombick, J., Adham, N., Vaysse, P., Branchek, T. A., and Weinshank, R. L. (1993). Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J. Biol. Chem. 268, 23422-23426.
7. Bjarnadottir, T. K., Gloriam, D. E., Hellstrand, S. H., Kristiansson, H., Fredriksson, R., and Schioth, H. B. (2006). Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse. Genomics 88, 263-273. doi: 10.1016/j.ygeno.2006.04.001
8. Bulenger, S., Marullo, S., and Bouvier, M. (2005). Emerging role of homo-and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol. Sci. 26, 131-137. doi: 10.1016/j.tips.2005.01.004
9. Cabrera-Vera, T. M., Vanhauwe, J., Thomas, T. O., Medkova, M., Preininger, A., Mazzoni, M. R., et al. (2003). Insights into G protein structure, function and regulation. Endocr. Rev. 24, 765-781. doi: 10.1210/er.2000-0026
10. Choi, C., and Helfman, D. M. (2014). The Ras-ERK pathway modulates cytoskele-ton organization, cell motilityand lung metastasis signature genes in MDA-MB-231 LM2. Oncogene 33, 3668-3676. doi: 10.1038/onc.2013.341
11. Christopoulos, A., and Kenakin, T. (2002). G protein-coupled receptor allosterism and complexing. Pharmacol. Rev. 54, 323-374. doi: 10.1124/pr.54.2.323
12. Citri, A., and Malenka, R. C. (2008). Synaptic plasticity: multiple forms, functions and mechanisms. Neuropsychopharmacology 33, 18-41. doi: 10.1038/sj.npp. 1301559
13. Cooper, D. M., Mons, N., and Karpen, J. W. (1995). Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature 374, 421-424. doi: 10. 1038/374421a0
14. Devi, L. A. (2001). Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking. Trends Pharmacol. Sci. 22, 532-537. doi: 10. 1016/s0165-6147(00)01799-5
15. Di Pilato, P., Niso, M., Adriani, W., Romano, E., Travaglini, D., Berardi, F., et al. (2014). Selective agonists for serotonin 7 (5-HT7) receptor and their applications in preclinical models: an overview. Rev. Neurosci. 25, 401-415. doi: 10.1515/revneuro-2014-0009
16. Dixon, R. A., Kobilka, B. K., Strader, D. J., Benovic, J. L., Dohlman, H. G., Frielle, T., et al. (1986). Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin. Nature 321, 75-79. doi: 10.1038/321075a0
17. Dogrul, A., and Seyrek, M. (2006). Systemic morphine produce antinociception mediated by spinal 5-HT7, but not 5-HT1A and 5-HT2 receptors in the spinal cord. Br. J. Pharmacol. 149, 498-505. doi: 10.1038/sj.bjp.0706854
18. East, S. Z., Burnet, P. W., Kerwin, R. W., and Harrison, P. J. (2002). An RT-PCR study of 5-HT(6) and 5-HT(7) receptor mRNAs in the hippocampal formation and prefrontal cortex in schizophrenia. Schizophr. Res. 57, 15-26. doi: 10.1016/s0920-9964(01)00323-1
19. Eriksson, T. M., Golkar, A., Ekstrom, J. C., Svenningsson, P., and Ogren, S. O. 5-HT7 receptor stimulation by 8-OH-DPAT counteracts the impairing effect of 5-HT(1A) receptor stimulation on contextual learning in mice. Eur. J. Pharmacol. 596, 107-110. doi: 10.1016/j.ejphar.2008.08.026
20. Errico, M., Crozier, R. A., Plummer, M. R., and Cowen, D. S. (2001). 5-HT(7) receptors activate the mitogen activated protein kinase extracellular signal related kinase in cultured rat hippocampal neurons. Neuroscience 102, 361-367. doi: 10.1016/s0306-4522(00)00460-7
21. Escriba, P. V., Wedegaertner, P. B., Goni, F. M., andVogler, O. (2007). Lipid-protein interactions in GPCR-associated signaling. Biochim. Biophys. Acta 1768, 836852. doi: 10.1016/j.bbamem.2006.09.001
22. Ford, C. E., Skiba, N. P., Bae, H., Daaka, Y., Reuveny, E., Shekter, L. R., et al. (1998). Molecular basis for interactions of G protein betagamma subunits with effectors. Science 280, 1271-1274. doi: 10.1126/science.280.5367.1271
23. Gasbarri, A., Cifariello, A., Pompili, A., and Meneses, A. (2008). Effect of 5-HT(7) antagonist SB-269970 in the modulation of working and reference memory in the rat. Behav. Brain Res. 195, 164-170. doi: 10.1016/j.bbr.2007.12.020
24. Gehret, A. U., and Hinkle, P. M. (2010). Importance ofregions outside the cytoplasmic tail of G-protein-coupled receptors for phosphorylation and dephosphorylation. Biochem. J. 428, 235-245. doi: 10.1042/bj20100139
25. Gellynck, E., Andressen, K. W., Lintermans, B., Haegeman, G., Levy, F. O., Vanhoenacker, P., et al. (2012). Biochemical and pharmacological study of N-linked glycosylation of the human serotonin 5-HT7a receptor. FEBS J. 279, 1994-2003. doi: 10.1111/j.1742-4658.2012.08581.x
26. Gorinski, N., and Ponimaskin, E. (2013). Palmitoylation of serotonin receptors. Biochem. Soc. Trans. 41, 89-94. doi: 10.1042/BST20120235
27. Guscott, M., Bristow, L. J., Hadingham, K., Rosahl, T. W., Beer, M. S., Stanton, J. A., et al. (2005). Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression. Neuropharmacology 48, 492-502. doi: 10.1016/j.neuropharm.2004.11.015
28. Guscott, M. R., Egan, E., Cook, G. P., Stanton, J. A., Beer, M. S., Rosahl, T. W., et al. (2003). The hypothermic effect of 5-CT in mice is mediated through the 5-HT7 receptor. Neuropharmacology 44, 1031-1037. doi: 10.1016/s0028-3908(03)00117-5
29. Guseva, D., Holst, K., Kaune, B., Meier, M., Keubler, L., Glage, S., et al. (2014). Serotonin 5-HT7 receptor is critically involved in acute and chronic inflammation of the gastrointestinal tract. Inflamm. BowelDis. 20,1516-1529. doi: 10.1097/MIB.0000000000000150
30. Guthrie, C. R., Murray, A. T., Franklin, A. A., and Hamblin, M. W. (2005). Differential agonist-mediated internalization of the human 5-hydroxytryptamine 7 receptor isoforms. J. Pharmacol. Exp. Ther. 313, 1003-1010. doi: 10.1124/jpet. 104.081919
31. Hart, M. J., Jiang, X., Kozasa, T., Roscoe, W., Singer, W. D., Gilman, A. G., et al. (1998). Direct stimulation of the guanine nucleotide exchange activity ofp115 RhoGEF by Galpha13. Science 280, 2112-2114. doi: 10.1126/science.280.5372.2112
32. Hedlund, P. B. (2009). The 5-HT7 receptor and disorders of the nervous system: an overview. Psychopharmacology (Berl) 206, 345-354. doi: 10.1007/s00213-009-1626-0
33. Hedlund, P. B., Huitron-Resendiz, S., Henriksen, S. J., and Sutcliffe, J. G. (2005). 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern. Biol. Psychiatry 58, 831-837. doi: 10.1016/j.biopsych.2005.05. 012
34. Hedlund, P. B., and Sutcliffe, J. G. (2004). Functional, molecular and pharmacological advances in 5-HT7 receptor research. Trends Pharmacol. Sci. 25, 481-486. doi: 10.1016/j.tips.2004.07.002
35. Heidmann, D. E., Metcalf, M. A., Kohen, R., and Hamblin, M. W. (1997). Four 5-hydroxytryptamine7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron-exon organization. J. Neurochem. 68, 1372-1381. doi: 10.1046/j.1471-4159.1997.68041372.x
36. Heidmann, D. E., Szot, P., Kohen, R., and Hamblin, M. W. (1998). Function and distribution of three rat 5-hydroxytryptamine7 (5-HT7) receptor isoforms produced by alternative splicing. Neuropharmacology 37, 1621-1632. doi: 10. 1016/s0028-3908(98)00070-7
37. Hiley, E., McMullan, R., and Nurrish, S. J. (2006). The Galpha12-RGS RhoGEF-RhoA signalling pathway regulates neurotransmitter release in C. elegans. EMBO J. 25, 5884-5895. doi: 10.1038/sj.emboj.7601458
38. Horisawa, T., Ishiyama, T., Ono, M., Ishibashi, T., and Taiji, M. (2013). Binding of lurasidone, a novel antipsychotic, to rat 5-HT7 receptor: analysis by [3H]SB-269970 autoradiography. Prog. Neuropsychopharmacol. Biol. Psychiatry 40, 132137. doi: 10.1016/j.pnpbp.2012.08.005
39. Ibata, K., Sun, Q., and Turrigiano, G. G. (2008). Rapid synaptic scaling induced by changes in postsynaptic firing. Neuron 57, 819-826. doi: 10.1016/j.neuron.2008. 02.031
40. Ikeda, M., Iwata, N., Kitajima, T., Suzuki, T., Yamanouchi, Y., Kinoshita, Y., et al. (2006). Positive association of the serotonin 5-HT7 receptor gene with schizophrenia in a Japanese population. Neuropsychopharmacology 31, 866-871. doi: 10.1038/sj.npp.1300901
41. Impey, S., Wayman, G., Wu, Z., and Storm, D. R. (1994). Type I adenylyl cyclase functions as a coincidence detector for control of cyclic AMP response element-mediated transcription: synergistic regulation of transcription by Ca2+ and isoproterenol. Mol. Cell. Biol. 14, 8272-8281.
42. Johnson-Farley, N. N., Kertesy, S. B., Dubyak, G. R., and Cowen, D. S. (2005). Enhanced activation of Akt and extracellular-regulated kinase pathways by simultaneous occupancy of Gq-coupled 5-HT2A receptors and Gs-coupled 5-HT7A receptors in PC12 cells. J. Neurochem. 92, 72-82. doi: 10.1111/j.1471-4159.2004.02832.x
43. Kelly, P., Casey, P. J., and Meigs, T. E. (2007). Biologic functions ofthe G12 subfamily of heterotrimeric g proteins: growth, migration and metastasis. Biochemistry 46, 6677-6687.doi: 10.1021/bi700235f
44. Knight, J. A., Smith, C., Toohey, N., Klein, M. T., and Teitler, M. (2009). Pharmacological analysis of the novel, rapid and potent inactivation of the human 5-Hydroxytryptamine7 receptor by risperidone, 9-OH-Risperidone and other inactivating antagonists. Mol. Pharmacol. 75, 374-380. doi: 10.1124/mol.108. 052084
45. Kobe, F., Guseva, D., Jensen, T. P., Wirth, A., Renner, U., Hess, D., et al. (2012). 5-HT7R/G12 signaling regulates neuronal morphology and function in an age-dependent manner. J. Neurosci. 32, 2915-2930. doi: 10.1523/JNEUROSCI.2765-11.2012
46. Kozasa, T., Jiang, X., Hart, M. J., Sternweis, P. M., Singer, W. D., Gilman, A. G., et al. (1998). p115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13. Science 280, 2109-2111. doi: 10.1126/science.280.5372.2109
47. Kristiansen, K. (2004). Molecular mechanisms of ligand binding, signaling and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol. Ther. 103, 21-80. doi: 10.1016/j.pharmthera.2004.05.002
48. Krobert, K.A., Bach, T., Syversveen, T., Kvingedal, A. M., andLevy, F. O. (2001). The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution. Naunyn Schmiedebergs Arch. Pharmacol. 363, 620-632. doi: 10.1007/s002100000369
49. Krupnick, J. G., and Benovic, J. L. (1998). The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu. Rev. Pharmacol. Toxicol. 38, 289-319. doi: 10.1146/annurev.pharmtox.38.1.289
50. Krupinski, J., Coussen, F., Bakalyar, H. A., Tang, W. J., Feinstein, P. G., Orth, K., et al. (1989). Adenylyl cyclase amino acid sequence: possible channel-or transporterlike structure. Science 244, 1558-1564. doi: 10.1126/science.2472670
51. Kvachnina, E., Dumuis, A., Wlodarczyk, J., Renner, U., Cochet, M., Richter, D. W., et al. (2009). Constitutive Gs-mediated, but not G12-mediated, activity of the 5-hydroxytryptamine 5-HT7(a) receptor is modulated bythe palmitoylation of its C-terminal domain. Biochim. Biophys. Acta 1793, 1646-1655. doi: 10.1016/j.bbamcr.2009.08.008
52. Kvachnina, E., Liu, G., Dityatev, A., Renner, U., Dumuis, A., Richter, D. W., et al. (2005). 5-HT7 receptor is coupled to G alpha subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology. J. Neurosci. 25, 7821-7830. doi: 10.1523/jneurosci.1790-05.2005
53. Kyriakis, J. M., App, H., Zhang, X. F., Banerjee, P., Brautigan, D. L., Rapp, U. R., et al. (1992). Raf-1 activates MAP kinase-kinase. Nature 358, 417-421. doi: 10. 1038/358417a0
54. Lefkowitz, R. J., and Shenoy, S. K. (2005). Transduction of receptor signals by beta-arrestins. Science 308, 512-517. doi: 10.1126/science.1109237
55. Li, Z., Aizenman, C. D., and Cline, H. T. (2002). Regulation of rho GTPases by crosstalk and neuronal activityin vivo. Neuron 33, 741-750. doi: 10.1016/s0896-6273(02)00621-9
56. Li, P., Wood, K., Mamon, H., Haser, W., and Roberts, T. (1991). Raf-1: a kinase currently without a cause but not lacking in effects. Cell 64, 479-482. doi: 10. 1016/0092-8674(91)90228-q
57. Lin, S. L., Johnson-Farley, N. N., Lubinsky, D. R., and Cowen, D. S. (2003). Coupling of neuronal 5-HT7 receptors to activation of extracellular-regulated kinase through a protein kinase A-independent pathway that can utilize Epac. J. Neurochem. 87, 1076-1085. doi: 10.1046/j.1471-4159.2003.02076.x
58. Liu, H., Irving, H. R., and Coupar, I. M. (2001). Expression patterns of 5-HT7 receptor isoforms in the rat digestive tract. Life Sci. 69, 2467-2475. doi: 10. 1016/s0024-3205(01)01318-2
59. Logothetis, D. E., Kurachi, Y., Galper, J., Neer, E. J., and Clapham, D. E. (1987). The beta gamma subunits of GTP-binding proteins activate the muscarinic K+ channel in heart. Nature 325, 321-326. doi: 10.1038/325321a0
60. Lovenberg, T. W., Baron, B. M., de Lecea, L., Miller, J. D., Prosser, R. A., Rea, M. A., et al. (1993). A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron 11, 449458. doi: 10.1016/0896-6273(93)90149-l
61. Manser, E., Leung, T., Salihuddin, H., Zhao, Z. S., and Lim, L. (1994). A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 367, 4046. doi: 10.1038/367040a0
62. Meigs, T. E., Fields, T. A., McKee, D. D., and Casey, P. J. (2001). Interaction of Galpha 12 and Galpha 13 with the cytoplasmic domain of cadherin provides a mechanism for beta-catenin release. Proc. Natl. Acad. Sci. USA 98, 519-524. doi: 10.1073/pnas.021350998
63. Mnie-Filali, O., Lambas-Senas, L., Scarna, H., and Haddjeri, N. (2009). Therapeutic potential of 5-HT7 receptors in mood disorders. Curr. Drug Targets 10, 11091117. doi: 10.2174/138945009789735129
64. Montgomery, E. R., Temple, B. R., Peters, K. A., Tolbert, C. E., Booker, B. K., Martin, J. W., et al. (2014). Ga12 structural determinants of Hsp90 interaction are necessary for serum response element-mediated transcriptional activation. Mol. Pharmacol. 85, 586-597. doi: 10.1124/mol.113.088443
65. Monti, J. M., and Jantos, H. (2014). The role of serotonin 5-HT7 receptor in regulating sleep andwakefulness. Rev. Neurosci. 25, 429-437. doi: 10.1515/revneuro-2014-0016
66. Mullins, U. L., Gianutsos, G., and Eison, A. S. (1999). Effects of antidepressants on 5-HT7 receptor regulation in the rat hypothalamus. Neuropsychopharmacology 21, 352-367. doi: 10.1016/s0893-133x(99)00041-x
67. Nathans, J., and Hogness, D. S. (1983). Isolation, sequence analysis and intron-exon arrangement of the gene encoding bovine rhodopsin. Cell 34, 807-814. doi: 10. 1016/0092-8674(83)90537-8
68. Nielsen, M. D., Chan, G. C., Poser, S. W., and Storm, D. R. (1996). Differential regulation of type I and type VIII Ca2+-stimulated adenylyl cyclases by Gi-coupled receptors in vivo. J. Biol. Chem. 271, 33308-33316. doi: 10.1074/jbc. 271.52.33308
69. Pery, S. J., Baillie, G. S., Kohout, T. A., McPhee, I., Magiera, M. M., Ang, K. L., et al. Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins. Science 298, 834-836. doi: 10.1126/science.1074683
70. Ponimaskin, E., Dumuis, A., Gaven, F., Barthet, G., Heine, M., Glebov, K., et al. (2005). Palmitoylation of the 5-hydroxytryptamine4a receptor regulates receptor phosphorylation, desensitization and beta-arrestin-mediated endocytosis. Mol. Pharmacol. 67, 1434-1443. doi: 10.1124/mol.104.008748
71. Ponimaskin, E. G., Profirovic, J., Vaiskunaite, R., Richter, D. W., and Voyno-Yasenetskaya, T. A. (2002). 5-Hydroxytryptamine 4(a) receptor is coupled to the Galphasubunit ofheterotrimeric G13 protein. J. Biol. Chem. 277, 20812-20819. doi: 10.1074/jbc.m112216200
72. Pouzet, B., Didriksen, M., and Arnt, J. (2002). Effects of the 5-HT(7) receptor antagonist SB-258741 in animal models for schizophrenia. Pharmacol. Biochem. Behav. 71, 655-665. doi: 10.1016/s0091-3057(01)00744-4
73. Premont, R. T., Matsuoka, I., Mattei, M. G., Pouille, Y., Defer, N., and Hanoune, J. (1996). Identification and characterization of a widely expressed form of adenylyl cyclase. J. Biol. Chem. 271, 13900-13907. doi: 10.1074/jbc.271.23. 13900
74. Qian, Y., Corum, L., Meng, Q., Blenis, J., Zheng, J. Z., Shi, X., et al. (2004). PI3K induced actin filament remodeling through Akt and p70S6K1: implication of essential role in cell migration. Am. J. Physiol. Cell Physiol. 286, C153-C163. doi: 10.1152/ajpcell.00142.2003
75. Renner, U., Zeug, A., Woehler, A., Niebert, M., Dityatev, A., Dityateva, G., et al. Heterodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates receptor signalling and trafficking. J. Cell Sci. 125, 2486-2499. doi: 10.1242/jcs.101337
76. Ruat, M., Traiffort, E., Leurs, R., Tardivel-Lacombe, J., Diaz, J., Arrang, J. M., et al. Molecular cloning, characterization and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc. Natl. Acad. Sci. USA 90, 8547-8551. doi: 10.1073/pnas.90.18.8547
77. Russo, A., Pellitteri, R., Monaco, S., Romeo, R., and Stanzani, S. (2005). “In vitro” postnatal expression of 5-HT7 receptors in the rat hypothalamus: an immunohistochemical analysis. Brain Res. Dev. Brain Res. 154,211-216. doi: 10. 1016/j.devbrainres.2004.11.002
78. Seifert, R., and Wenzel-Seifert, K. (2002). Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch. Pharmacol. 366, 381-416. doi: 10. 1007/s00210-002-0588-0
79. Shen, Y., Monsma, F. J. Jr., Metcalf, M. A., Jose, P. A., Hamblin, M. W., and Sibley, D. R. (1993). Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J. Biol. Chem. 268, 18200-18204.
80. Smith, C., Rahman, T., Toohey, N., Mazurkiewicz, J., Herrick-Davis, K., and Teitler, M. (2006). Risperidone irreversibly binds to and inactivates the h5-HT7 serotonin receptor. Mol. Pharmacol. 70, 1264-1270. doi: 10.1124/mol.106. 024612
81. Smith, C., Toohey, N., Knight, J. A., Klein, M. T., and Teitler, M. (2011). Risperidone-induced inactivation and clozapine-induced reactivation ofrat cortical astrocyte 5-hydroxytryptamine7 receptors: evidence for in situ G protein-coupledreceptor homodimer protomer cross-talk. Mol. Pharmacol. 79, 318-325. doi: 10.1124/mol.110.069278
82. Speranza, L., Chambery, A., Di Domenico, M., Crispino, M., Severino, V., Volpicelli, F., et al. (2013). The serotonin receptor 7 promotes neurite outgrowth via ERK and Cdk5 signaling pathways. Neuropharmacology 67, 155-167. doi: 10.1016/j.neuropharm.2012.10.026
83. Sunahara, R. K., Dessauer, C. W., and Gilman, A. G. (1996). Complexity and diversity of mammalian adenylyl cyclases. Annu. Rev. Pharmacol. Toxicol. 36, 461-480. doi: 10.1146/annurev.pharmtox.36.1.461
84. Taussig, R., and Gilman, A. G. (1995). Mammalian membrane-bound adenylyl cyclases. J. Biol. Chem. 270, 1-4. doi: 10.1074/jbc.270.1.1
85. Teitler, M., Toohey, N., Knight, J. A., Klein, M. T., and Smith, C. (2010). Clozapine and other competitive antagonists reactivate risperidone-inactivated h5-HT7 receptors: radioligand binding and functional evidence for GPCR homodimer protomer interactions. Psychopharmacology (Berl) 212, 687-697. doi: 10. 1007/s00213-010-2001-x
86. Thomas, D. R., and Hagan, J. J. (2004). 5-HT7 receptors. Curr. Drug Targets CNS Neurol. Disord. 3, 81-90. doi: 10.2174/1568007043482633
87. Thompson, M. D., Cole, D. E., and Jose, P. A. (2008). Pharmacogenomics of G protein-coupled receptor signaling: insights from health and disease. Methods Mol. Biol. 448, 77-107. doi: 10.1007/978-1-59745-205-2_6
88. Tokarski, K., Zelek-Molik, A., Duszynska, B., Sataia, G., Bobula, B., Kusek, M., et al. (2012). Acute and repeated treatment with the 5-HT7 receptor antagonist SB 269970 induces functional desensitization of 5-HT7 receptors in rat hippocampus. Pharmacol. Rep. 64, 256-265. doi: 10.1016/s1734-1140(12) 70763-6
89. Toohey, N., Klein, M. T., Knight, J., Smith, C., and Teitler, M. (2009). Human 5-HT7 receptor-induced inactivation of forskolin-stimulated adenylate cyclase by risperidone, 9-OH-risperidone and other “inactivating antagonists”. Mol. Pharmacol. 76, 552-559. doi: 10.1124/mol.109.056283
90. Vasefi, M. S., Yang, K., Li, J., Kruk, J. S., Heikkila, J. J., Jackson, M. F., et al. (2013). Acute 5-HT7 receptor activation increases NMDA-evoked currents and differentially alters NMDA receptor subunit phosphorylation and trafficking in hippocampal neurons. Mol. Brain 6:24. doi: 10.1186/1756-6606-6-24
91. Waheed, A. A., and Jones, T. L. (2002). Hsp90 interactions and acylation target the G protein Galpha 12 but not Galpha 13to lipid rafts. J. Biol. Chem. 277, 3240932412. doi: 10.1074/jbc.c200383200
92. Wayman, G. A., Impey, S., Wu, Z., Kindsvogel, W., Prichard, L., and Storm, D. R. Synergistic activation of the type I adenylyl cyclase by Ca2+ and Gs-coupledreceptors invivo. J. Biol. Chem. 269, 25400-25405.
93. Wesoiowska, A., Tatarczyriska, E., Nikiforuk, A., and Chojnacka-Wojcik, E. (2007). Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice. Eur. J. Pharmacol. 555, 43-47. doi: 10.1016/j.ejphar.2006.10.001
94. Woehler, A., and Ponimaskin, E. G. (2009). G protein-mediated signaling: same receptor, multiple effectors. Curr. Mol. Pharmacol. 2, 237-248. doi: 10.2174/1874467210902030237